Farzad SHIDFAR, Shima JAZAYERI, Seyedeh Neda MOUSAVI, Mojtaba MALEK, Agha fateme HOSSEINI, Basmeh KHOSHPEY
Animal studies have shown antioxidant effects of Royal Jelly (RJ) and its effect on insulin resistance as the most common complication of Type 2 diabetes. This study was conducted to determine the effect of RJ intake on serum total antioxidant capacity, Malondialdehyde and insulin resistance in T2DM.
In this randomized controlled trial, forty-six type 2 diabetic patients, aged 25–65 years, with BMI of 20–30 kg/m2, and HbA1c of 6–8% were included. The patients were randomly assigned to receive 1000 mg of RJ supplement or placebo, 3 times daily for 8 weeks. HOMA-IR, anthropometric measurements, fasting blood glucose, serum insulin, total antioxidant capacity and malondialdehyde level were measured.
In comparison with placebo, HOMA-IR decreased (P=0.015) while serum total antioxidant capacity increased significantly in RJ group (P=0.016). No significant difference was detected for serum insulin and MDA in two groups.
RJ intake may have favorable effects on serum TAC and HOMA-IR in diabetic patients.
* THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS IS NOT INTENDED TO DIAGNOSE, TREAT CURE OR PREVENT ANY DISEASE.